Press release by the Shihlin District Prosecutors Office, Taiwan
2016.Dec.30
Announcement of the signing of a Non-Binding Letter of Intent for OBI Pharma, Inc., to issue new shares to AbProtix, Inc., in exchange for up to 70% stake in AP Biosciences
2016.Dec.22
Clarification on the news article by Economic Daily News
2016.Nov.23
OBI Pharma granted patent approval for its 2nd Generation Active Immunotherapy Treatment by Taiwan and Australia
2016.Nov.04
Clarification on the news article by Economic Daily News E-Paper
2016.Sep.23
To clarify the media report
2016.Sep.08
Additional charges on Next Digital Ltd., Hong Kong
2016.Sep.07
The company was invited to participate in 17th Annual Asian Technology Conference organized by Credit Suisse
2016.Aug.31
To clarify the media report
2016.Aug.10
OBI Pharma Inc. announces the change of VP, Chief Medical Officer